Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”

CCR2 depletion decreases lipid accumulation in the liver and WAT. by Seung Joo Lee (1766020)

“…Increased lipid droplets and fat size in HFD WT were decreased in HFD KO. Arrow indicates a crown-like structure. …”

Knockout or inhibition of CCR1 decreases peritoneal inflammation and CAIA. by Nuruddeen D. Lewis (192385)

Extent of demyelination is decreased following NgR knock down. by Fereshteh Pourabdolhossein (624998)

Acute JMV2959 treatment decreases alcohol intake in rats. by Petra Suchankova (400313)

“…JMV2959 significantly decreases voluntary alcohol consumption compared to vehicle and the effect was more pronounced after five compared to two months of alcohol consumption. …”

HSC activation results in a preferential decrease in retinyl esters. by Nicole Testerink (169448)

SF decreases the expression of mRNAs involved in tumor progression. by Mirjana Dačević (289285)

Submandibular gland removal decreases avoidance of bitter taste in mice by Masataka Narukawa (20599511)

Brivanib decreases the transcription of growth factors and their receptors in carbon tetrachloride. by Ikuo Nakamura (548298)

“…<p>Hepatic levels of growth factors and growth factor receptor mRNA were measured by real time PCR in sham and CCl₄ mice treated with no brivanib or with brivanib 25 mg/kg, 50 mg/kg, or 100 mg/kg. In all of the sham experiments, higher concentrations of brivanib decreased the mRNA levels of the growth factors and their receptors. …”

Cellular viability decreases in breast cancer cells treated with clotrimazole. by Cristiane M. Furtado (333360)

Monotonically decreasing gene expression in MX-treated TA100 by William O Ward (39946)

VEGFR2/VEGF-A ligand binding decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

Fig 2 - by Diana Xochiquetzal Robledo-Cadena (5265959)

The expression of miR-214 (A) and the activating transcription factor 4 (<i>ATF4</i>) target gene (B) after treating K562 cells with 25, 50, and 75 μM of hemin for 48 h. by Tipparat Penglong (164413)

Adenosine inhibits AMPA EPSCs by decreasing presynaptic glutamate release. by Shouping Wang (402959)

Reverse activation tendency decreases for spikes occurring later in SWRs by Jozsef Csicsvari (82625)

PTB is associated with decreased antigen-stimulated production of IL-4. by Nathella Pavan Kumar (129299)

Protease treatment decreases binding of LGTV to A549 cells. by Raquel Rodrigues (221129)

Stable knockdown of JTB in HCC cells decreases cell apoptosis. by Yun-Peng Liu (108506)

sEH deficiency decreases cerulein-induced pancreatic injury. by Ahmed Bettaieb (173694)